These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
558 related articles for article (PubMed ID: 30350853)
1. ILC-poiesis: Ensuring tissue ILC differentiation at the right place and time. Lim AI; Di Santo JP Eur J Immunol; 2019 Jan; 49(1):11-18. PubMed ID: 30350853 [TBL] [Abstract][Full Text] [Related]
2. Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation. Lim AI; Li Y; Lopez-Lastra S; Stadhouders R; Paul F; Casrouge A; Serafini N; Puel A; Bustamante J; Surace L; Masse-Ranson G; David E; Strick-Marchand H; Le Bourhis L; Cocchi R; Topazio D; Graziano P; Muscarella LA; Rogge L; Norel X; Sallenave JM; Allez M; Graf T; Hendriks RW; Casanova JL; Amit I; Yssel H; Di Santo JP Cell; 2017 Mar; 168(6):1086-1100.e10. PubMed ID: 28283063 [TBL] [Abstract][Full Text] [Related]
4. Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells. Eken A; Yetkin MF; Vural A; Okus FZ; Erdem S; Azizoglu ZB; Haliloglu Y; Cakir M; Turkoglu EM; Kilic O; Kara I; Dönmez Altuntaş H; Oukka M; Kutuk MS; Mirza M; Canatan H Front Immunol; 2019; 10():217. PubMed ID: 30828332 [TBL] [Abstract][Full Text] [Related]
5. Metabolic Control of Innate Lymphoid Cell Migration. Willinger T Front Immunol; 2019; 10():2010. PubMed ID: 31507605 [TBL] [Abstract][Full Text] [Related]
6. Dissecting human ILC heterogeneity: more than just three subsets. Simoni Y; Newell EW Immunology; 2018 Mar; 153(3):297-303. PubMed ID: 29140572 [TBL] [Abstract][Full Text] [Related]
7. Development of Human ILCs and Impact of Unconventional Cytotoxic Subsets in the Pathophysiology of Inflammatory Diseases and Cancer. Calvi M; Di Vito C; Frigo A; Trabanelli S; Jandus C; Mavilio D Front Immunol; 2022; 13():914266. PubMed ID: 35720280 [TBL] [Abstract][Full Text] [Related]